To study Thy1 as a fibroblast marker, SSEA1 as a marker of intermediate pluripotency, and Oct4 as a marker of established pluripotency in rat model of endometriosis.
Design:
In vivo animal study.
Materials and Methods:
Endometriosis was induced in 20 albino female rats through autologous transplantation of one uterine horn to mesentery of intestine. Other 20 rats had their horn removed without transplantation (controls). Rats were sacrificed 4 weeks after induction surgery. Ectopic, eutopic, and control endometria were harvested from endometriosis and control animals respectively. Quantitative syber green based RT-PCR was used to detect expression of Thy-1 (CD90), FUT4 (SSEA1), and POU5F1 (Oct4) genes in tissues. Relative expression was normalized to that of β actin. Thy1, SSEA1, and Oct4 protein expression were detected by immunohistochemistry.
Results:
Ectopic endometrium expressed significantly higher mRNA of Oct4 and SSEA1 as compared to control endometrium. Expression levels of Oct4 and SSEA1 were comparable between ectopic and eutopic endometria and between eutopic and control endometria. Thy1 (CD90) gene expression level was comparable among ectopic, eutopic, and control endometria. Oct4 immunoscore were significantly higher in ectopic (6.6±0.91) than eutopic (2.5±0.78) or control endometrium (3.7±0.1) (P value 0.02). Thy1 and SSEA1 immunoscores were comparable among all three types of endometria.
Conclusions:
Using rat model of endometriosis, ectopic endometrium showed significantly higher Oct4, and SSEA1, but similar Thy1 gene expression to that of control endometrium. This indicates increased transition from somatic to pluripotent cell states in ectopic endometrium which may play a role in endometriosis pathogenesis.
SchleedoornMJNelenWLDunselmanGAVermeulenNEndokeyGroup. Endokey Group. Selection of key recommendations for the management of women with endometriosis by an international panel of patients and professionals. Hum Reprod. 2016;31(6):1208–18.
2.
OthmanERHornungDHusseinM. Soluble tumor necrosis alpha receptors in the serum of endometriosis patients. Eur J Obstet Gynecol Reprod Biol. 2016;200:1–5.
3.
EskenaziBWarnerML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24(2):235–258.
4.
KappouDMatalliotakisMMatalliotakisI. Medical treatments for endometriosis. Minerva Ginecol. 2010;62(5):415–432.
5.
FalconeTLebovicD. Clinical management of endometriosis. Obstet Gynecol. 2011;118(3):691–705.
6.
GiudiceL. Clinical practice: endometriosis. N Engl J Med. 2010;362(25):2389–2398.
7.
DunselmanGAVermeulenNBeckerC; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412.
8.
ShakibaKBenaJMcGillKMingeJFalconeT. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285–1292.
9.
NnoahamKEHummelshojLWebsterP; World Endometriosis Research Foundation Global Study of Women’s Health consortium. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366–373.
RogersPAD’HoogheTMFazleabasA. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis in Montpellier, France. Reprod Sci. 2013;20(5):483–499.
12.
BurneyROGiudiceLC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519.
13.
SampsonJA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14(4):422–469.
14.
BulunSE. Endometriosis. N Engl J Med. 2009;360(3):268–279.
15.
DuHTaylorHS. Stem cells and female reproduction. Reprod Sci. 2009;16(2):126–139.
16.
ChanRWSchwabKEGargettCE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod. 2004;70(6):1738–1750.
17.
GargettCESchwabKEZillwoodRMNguyenHPWuD. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod. 2009;80(6):1136–1145.
18.
MintsMJanssonMSadeghiB. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Hum Reprod. 2008;23(1):139.
19.
TaylorHS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004;292(1):81–85.
20.
IkomaTKyoSMaidaY. Bone marrow-derived cells from male donors can compose endometrial glands in female transplant recipients. Am J Obstet Gynecol. 2009;201(6):608.e1–608.e8.
21.
WolffEFWolffABHonglingDuTaylorHS. Demonstration of multipotent stem cells in the adult human endometrium by in vitro chondrogenesis. Reprod Sci. 2007;14(6):524–533.
22.
DimitrovRTimevaTKyurkchievD. Characterization of clonogenic stromal cells isolated from human endometrium. Reproduction. 2008;135(4):551–558.
23.
GargettCESchwabKEBrosensJJPuttemansPBenagianoGBrosensI. Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis. Mol Hum Reprod. 2014;20(7):591–598.
24.
FigueiraPGAbrãoMSKrikunGTaylorHS. Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann N Y Acad Sci. 2011;1221:10–17.
25.
HufnagelDLiFCosarEKrikunGTaylorHS. Role of stem cells in the etiology and pathophysiology of endometriosis. Semin Reprod Med. 2015;33(5):333–340.
26.
ChanRWNgEHYeungWS. Identification of cells with colony forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. Am J Pathol. 2011;178(6):2832–2844.
27.
DjokovicDCalhaz-JorgeC. Somatic stem cells and their dysfunction in endometriosis. Front Surg. 2014;1:51.
28.
DuHTaylorHS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells. 2007;25(8):2082–2086.
29.
TakahashiKYamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676.
30.
YuJVodyanikMASmuga-OttoK. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–1920.
31.
DaleyG. Common themes of dedifferentiation in somatic cell reprogramming and cancer. Cold Spring Harb Symp Quant Biol. 2008;73:171–174.
32.
Friedmann-MorvinskiDVermaIM. Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep. 2014;15(3):244–235.
33.
BachooRMMaherEALigonKL. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell. 2002;1(3):269–277.
34.
Friedmann-MorvinskiDBushongEAKeE. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science. 2012;338(6110):1080–1084.
35.
SodaYMarumotoTFriedmann-MorvinskiD. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A. 2011;108(11):4274–4280.
36.
SchwitallaSFingerleAACammareriP. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem cell-like properties. Cell. 2013;152(1-2):25–38.
37.
ChafferCLMarjanovicNDLeeT. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell. 2013;154(1):61–74.
38.
Gidekel FriedlanderSYChuGCSnyderEL. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell. 2009;16(5):379–389.
39.
KumarSMLiuSLuH. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 2012;31(47):4898–4911.
40.
PelchKESchroderALKimballPASharpe-TimmsKLDavisJWNagelSC. Aberrant gene expression profile in mouse model of endometriosis mirrors that observed in women. Fertil Steril. 2010;93(5):1615–1162.
41.
VernonMWWilsonEA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694.
42.
Sharpe-TimmsKL. Using rats as a research model for the study of endometriosis. Ann N Y Acad Sci. 2002;955:318–327; discussion 340-342, 396-406.
43.
GotteMWolfMStaeblerA. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol. 2008;215(3):317–329.
44.
ForteASchettinoMTFinicelliM. Expression pattern of stemness-related genes in human endometrial and endometriotic tissues. Mol Med. 2009;15(11-12):392–401.
45.
SongYXiaoLFuJ. Increased expression of the pluripotency markers sex-determining region Y-box 2 and Nanog homeobox in ovarian endometriosis. Reprod Biol Endocrinol. 2014;12:42.
46.
KaoAPWangKHChangCC. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril. 2011;95(4):1308–1315.e1.
47.
MoggioAPittatoreGCassoniPMarchinoGLRevelliABussolatiB. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis. Fertil Steril. 2012;98(6):1521–1530.e1522.
48.
NyholtDRLowSKAndersonCA. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet. 2012;44(12):1355–1359.
49.
LeyendeckerGHerbertzMKunzGMallG. Endometriosis results from the dislocation of basal endometrium. Hum Reprod. 2002;17(10):2725–2736.
50.
GargettCEMasudaH. Adult stem cells in the endometrium. Mol Hum Reprod. 2010;16(11):818–834.
51.
SassonIETaylorHS. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci. 2008;1127:106–115.
52.
ValentijnAJPalialKAl-LameeH. SSEA-1 isolates human endometrial basal glandular epithelial cells: phenotypic and functional characterization and implications in the pathogenesis of endometriosis. Hum Reprod. 2013;28(10):2695–2708.
53.
GargettCESchwabKEDeaneJA. Endometrial stem/ progenitor cells: the first 10 years. Hum Reprod Update. 2016;22(2):137–163.
54.
BratincsákABrownsteinMJCassiani-IngoniR. CD45-positive blood cells give rise to uterine epithelial cells in mice. Stem Cells. 2007;25(11):2820–2826.
55.
MorelliSSRameshwarPGoldsmithLT. Experimental evidence for bone marrow as a source of non-hematopoietic endometrial stromal and epithelial compartment cells in a murine model. Biol Reprod. 2013;89(1):7.
56.
BeckerCMBeaudryPFunakoshiT. Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis. Am J Pathol. 2011;178(4):1782–1791.
57.
KulakJJrFischerCKommBTaylorHS. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology. 2011;152(8):3226–3232.
58.
SakrSNaqviHKommBTaylorHS. Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology. 2014;155(4):1489–1497.
59.
WangXMamillapalliRMutluLDuHTaylorHS. Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression. Stem Cell Res (Amst). 2015;15(1):14–22.
60.
RuizASalvoVARuizLABáezPGarcíaMFloresI. Basal and steroid hormone-regulated expression of CXCR4 in human endometrium and endometriosis. Reprod Sci. 2010;17(10):894–903.
61.
CervellóIGil-SanchisCMasA. Bone marrow-derived cells from male donors do not contribute to the endometrial side population of the recipient. PLoS One. 2012;7(1): e30260.
62.
KottonDNFabianAJMulliganRC. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol. 2005;33(4):328–334.
63.
DuffieldJSBonventreJV. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int. 2005;68(5):1956–1961.
64.
DuHNaqviHTaylorHS. Ischemia/reperfusion injury promotes and granulocyte colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium. Stem Cells Dev. 2012;21(18):3324–3331.
65.
AlawadhiFDuHCakmakHTaylorHS. Bone marrow-derived stem cell (BMDSC) transplantation improves fertility in a murine model of Asherman’s syndrome. PLoS One. 2014;9(5): e96662.
66.
ChafferCLBrueckmannIScheelC. Normal and neoplastic non stem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A. 2011;108(19):7950–7955.
67.
RoySGascardPDumontN. Rare somatic cells from human breast tissue exhibit extensive lineage plasticity. Proc Natl Acad Sci U S A. 2013;110(12):4598–4603.
68.
TataPRMouHPardo-SagantaA. Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature. 2013;503(7475):218–223.
69.
Van EsJHSatoTvan de WeteringM. Dll1 + secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol. 2012;14(10):1099–1104.
70.
VermeulenLDe SousaEMFvan der HeijdenM. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12(5):468–476.
71.
PoloJMAnderssenEWalshRM. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell. 2012;151(7):1617–1632.
72.
ChangJHAuHKLeeWC. Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis. Fertil Steril. 2013;99(5):1332–1339.
73.
GotteMWolfMStaeblerABuchweitzOKieselLSchuringAN. Aberrant expression of the pluripotency marker SOX-2 in endometriosis. Fertil Steril. 2011;95(1):338–341.
74.
GuptaPBChafferCLWeinbergRA. Cancer stem cells: mirage or reality?Nat Med. 2009;15(9):1010–1012.
75.
GrechukhinaOPetraccoRPopkhadzeS. A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis. EMBO Mol Med. 2012;4(3):206–217.
76.
González-RamosRDefrèreSDevotoL. Nuclear factor-kappa B: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil Steril. 2012;98(3):520–528.
77.
KaponisAIwabeTTaniguchiF. The role of NF-kappa B in endometriosis. Front Biosci (Schol Ed). 2012;4:1213–1234.
78.
MatsuzakiSDarchaC. In vitro effects of a small-molecule antagonist of the Tcf/ß-catenin complex on endometrial and endometriotic cells of patients with endometriosis. PLoS One. 2013;8(4): e61690.
79.
MatsuzakiSDarchaC. Involvement of the Wnt/β-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One. 2013;8(10): e76808.
